Primary Membranous Nephropathy Autoantibody Profile
Also known as: Membranous nephropathy, PLA2R, Primary membranous nephropathy, THSD7A
Use
This autoantibody profile is recommended for the evaluation of patients at risk for primary membranous nephropathy (PMN).
Special Instructions
If PLA2R Antibody, IgG is positive, then a PLA2R Antibody, IgG titer will be added. If THSD7A Antibody, IgG is positive, then a THSD7A Antibody, IgG titer will be added. This assay currently is not available in New York state. If reflex test is performed, additional charges/CPT code(s) may apply.
Limitations
This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.
Methodology
Cell-based / Cytometry (Flow Cytometry)
Biomarkers
LOINC Codes
- 82991-1
- 82991-1
- 81201-6
- 93689-8
Result Turnaround Time
5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
1 mL
Container
Gel-barrier tube, red-top tube or serum transfer tube
Collection Instructions
If a tube other than a gel-barrier tube is used, transfer the separated serum to a plastic transport tube. Do not freeze the gel-barrier tube (pour off the serum first).
Storage Instructions
Room temperature
Causes for Rejection
Gross hemolysis; grossly lipemic; gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant